Africa REACH is inviting proposals from organisations based in South Africa and Cote d'Ivoire that are working on evidence-based advocacy for access to long-acting options for HIV prevention and/or HIV treatment at the community and/or policy levels. This grant aims to support initiatives...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced that the European Commission has authorised Vocabria (cabotegravir long-acting injections) in combination with Johnson & Johnson’s Rekambys (rilpivirine long-acting injections) for the treatment of HIV-1 infection...

Africa REACH is proud to present our comprehensive Call to Action: Ending AIDS in Children in Africa. This document outlines the steps needed to accelerate progress in combating paediatric HIV. Despite significant achievements in preventing vertical transmission of HIV, there remain alarming gaps in treatment and...

April 7 was World Health Day under the theme 'My Health, My Right.' To echo this important message and amplify the voices of young people involved in the HIV response, as well as those living with HIV, Africa REACH and the Africa HIV Control Working...

As we reflect on the past 12 months, we recognise the need to catalyse a new action agenda. The urgency of our mission demands continuous innovation, bold initiatives, and a relentless pursuit of progress. We are not just commemorating a year gone by; we are launching ourselves into...